[Immunologic study of chrysotherapy intolerance using Shelley's test, the lymphoblastic transformation test and the leukocyte migration inhibition test].
D000328:Adult; D000419:Albuminuria / Q000209:etiology; D000799:Angioedema / Q000209:etiology; D000936:Antigen-Antibody Complex; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002464:Cell Migration Inhibition; D004342:Drug Hypersensitivity / Q000150:complications / Q000276:immunology*; D004485:Eczema / Q000209:etiology; D004890:Erythema / Q000209:etiology; D005260:Female; D006046:Gold / Q000009:adverse effects* / Q000627:therapeutic use; D006417:Hematuria / Q000209:etiology; D006801:Humans; D007962:Leukocytes; D008213:Lymphocyte Activation; D008875:Middle Aged; D011128:Polyradiculopathy / Q000209:etiology; D011537:Pruritus / Q000209:etiology; D012769:Shock / Q000209:etiology; D013280:Stomatitis / Q000209:etiology; D014581:Urticaria / Q000209:etiology
D000936:Antigen-Antibody Complex; D006046:Gold
Etude immunologique de l'intolérance a la chrysothérapie par le test de Shelley, le test de transformation lymphoblastique (TTL) et le test d'inhibition de la migration des leucocytes (TIML.